Consensus Boston Scientific Corporation

Equities

BSX

US1011371077

Market Closed - Nyse 21:00:02 24/05/2024 BST After market 23:30:10
75.63 USD +1.68% Intraday chart for Boston Scientific Corporation 77.44 +2.39%

Evolution of the average Target Price on Boston Scientific Corporation

Price target over the last 5 years

History of analyst recommendation changes

115cc02ff73b2b3.jp0xfz9gXPxH8W1pnYs3zVQUaSfUMFtGifa0JqS1Zzg.vfpnEA8PEYQ3w1hEyNFemGxTP2qMADxr6J7tXtTeNVfK_mgvTzIkrRaUHg~6eb41930432d2aef02ab902dbc23a211
Boston Scientific Insider Sold Shares Worth $2,504,239, According to a Recent SEC Filing MT
Citigroup Adjusts Price Target on Boston Scientific to $87 From $85, Keeps Buy Rating MT
CL King Adjusts Price Target on Boston Scientific to $90 From $82 MT
Mizuho Adjusts Price Target on Boston Scientific to $90 From $85, Keeps Buy Rating MT
Boston Scientific Insider Sold Shares Worth $958,717, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $286,874, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $1,257,488, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $499,075, According to a Recent SEC Filing MT
Boston Scientific Insider Sold Shares Worth $719,562, According to a Recent SEC Filing MT
Daiwa Adjusts Price Target on Boston Scientific to $81 From $73 MT
Redburn Atlantic Adjusts Price Target on Boston Scientific to $79 From $75 MT
UBS Raises Boston Scientific's Price Target to $90 From $74, Maintains Buy Rating MT
Oppenheimer Adjusts Boston Scientific's Price Target to $77 From $68 MT
Bernstein Adjusts Boston Scientific Price Target to $86 From $75 MT
Deutsche Bank Adjusts Price Target on Boston Scientific to $73 From $63 MT
Baird Adjusts Price Target on Boston Scientific to $84 From $79 MT
JPMorgan Adjusts Price Target on Boston Scientific to $82 From $72 MT
Raymond James Adjusts Boston Scientific Price Target to $85 From $73 MT
Wolfe Research Adjusts Boston Scientific Price Target to $81 From $72 MT
CL King Adjusts Boston Scientific's Price Target to $82 From $72 MT
Canaccord Genuity Adjusts Price Target on Boston Scientific to $83 From $81 MT
Barclays Adjusts Boston Scientific's Price Target to $78 From $70 MT
Wells Fargo Adjusts Price Target on Boston Scientific to $82 From $72 MT
Truist Raises Price Target on Boston Scientific to $86 From $79, Keeps Buy Rating MT
Needham Adjusts Price Target on Boston Scientific to $82 From $71 MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
74.38 USD
Average target price
81.53 USD
Spread / Average Target
+9.62%
High Price Target
90 USD
Spread / Highest target
+21.00%
Low Price Target
70 USD
Spread / Lowest Target
-5.89%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Boston Scientific Corporation

Citigroup
CL King
Mizuho Securities
Daiwa Securities
Redburn Atlantic
Wells Fargo Securities
Truist Securities
Barclays
Canaccord Genuity
Wolfe Research
Raymond James
JPMorgan Chase
Baird
Deutsche Bank Securities
Bernstein
Oppenheimer
UBS
Needham & Co.
RBC Capital Markets
BTIG
Morgan Stanley
Evercore ISI
Jefferies & Co.
Stifel Nicolaus
Piper Sandler
Nephron Research
Argus
TD Cowen
Goldman Sachs
BofA Securities
SVB Leerink
Credit Suisse
Atlantic Equities
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
  1. Stock Market
  2. Equities
  3. BSX Stock
  4. Consensus Boston Scientific Corporation